| Financial Year |
March 31 2023 |
| Monetary Funds |
256,579,004.74 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
79,396,071.06 |
| Accounts Receivable |
470,576,411.34 |
| Advances to Suppliers |
14,203,591.50 |
| Other Receivables |
11,122,008.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
274,323,284.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,060,417.99 |
| Total Current Assets |
1,158,735,070.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
26,094,294.91 |
| Fixed Assetes |
530,069,093.86 |
| Under-construction Projects |
8,139,946.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,447,656.53 |
| R&D expenses |
-- |
| Goodwill |
4,203,456.36 |
| Long-Term Deferred and Prepaid Expenses |
63,744,585.65 |
| Deferred Income Tax Assets |
24,906,481.02 |
| Other Non-Current Assets |
71,071,913.39 |
| Sub-Total of Non-Current Assets |
827,123,334.72 |
| Total Assets |
1,985,858,405.51 |
| Short-Term Loans |
495,551,833.36 |
| Trading Financial liabilities |
-- |
| Notes Payable |
85,476,586.51 |
| Accounts Payable |
319,377,065.86 |
| Accounts Received In Advance |
831,607.58 |
| Employee Compensation Payable |
31,137,442.95 |
| Taxes Payable |
9,305,164.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
32,121,594.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
52,189,608.00 |
| Other Current Liabilities |
68,562,487.46 |
| Sub-Total of Current Liabilities |
1,106,710,578.01 |
| Long-term Loans |
234,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,877,294.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
292,471,653.78 |
| Total Liabilities |
1,399,182,231.79 |
| Paid-In Capital(Or Share Stock) |
281,573,889.00 |
| Capital Surplus |
66,680,414.64 |
| Surplus Reserve |
70,313,339.37 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
82,361,192.21 |
| Minority Stockholder's Interest |
85,752,672.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
500,923,501.18 |
| Owner's Equity（Stockholder's Equity） |
586,676,173.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,985,858,405.51 |
